Latest Earnings Results: Q2 '26
Estimated EPS
$1.01
Reported EPS
$1.26
Surprise
+25.12%
Estimated Rev
$2.66B
Reported Rev
$2.85B
Surprise
+7.26%
$BHC Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.69 up 72.50% YoY • Reported revenue of $2.01B down -20.66% YoY • Bausch Health Companies Inc. raised its full-year 2026 guidance, now targeting consolidated revenues of $10.790-$11.040 billion, Adjusted EBITDA of $4.050-$4.175 billion, and Adjusted Cash Flows from Operations of $1.400-$1.475 billion.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $1.26 | -- | -- | N/A |
Q2 '26 | $1.01 | $1.26 | 25.12% | BEAT |
Q1 '26 | $0.67 | $0.78 | 16.13% | BEAT |
Q4 '25 | $1.20 | $1.08 | -10.58% | MISSED |
Q3 '25 | $1.06 | $1.16 | 9.53% | BEAT |